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Multi electrode arrays (MEAs) are increasingly used to detect external field potentials in electrically
active cells. Recently, in combination with cardiomyocytes derived from human (induced) pluripotent
stem cells they have started to become a preferred tool to examine newly developed drugs for potential
cardiac toxicity in pre-clinical safety pharmacology. The most important risk parameter is proarrhythmic
activity in cardiomyocytes which can cause sudden cardiac death. Whilst MEAs can provide medium- to
high- throughput noninvasive assay platform, the translation of a field potential to cardiac action po-
tential (normally measured by low-throughput patch clamp) is complex so that accurate assessment of
drug risk to the heart is in practice still challenging. To address this, we used computational simulation to
study the theoretical relationship between aspects of the field potential and the underlying cardiac
action potential. We then validated the model in both primary mouse- and human pluripotent (em-
bryonic) stem cell-derived cardiomyocytes showing that field potentials measured in MEAs could be
converted to action potentials that were essentially identical to those determined directly by electro-
physiological patch clamp. The method significantly increased the amount of information that could be
extracted from MEA measurements and thus combined the advantages of medium/high throughput with
more informative readouts. We believe that this will benefit the analysis of drug toxicity screening of
cardiomyocytes using in time and accuracy.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Multi electrode arrays (MEAs) have been developed to measure
electrical activity in neural and cardiac cells. They are now being
increasingly used specifically to analyze pharmacological toxicity of
newly developed or combinations of compounds on car-
diomyocytes of the heart. Most recently, in combination with car-
diomyocytes derived from human (induced) pluripotent stem cells
(hiPSC-CMs) they have started to emerge as powerful tools to
examine the ability of certain compounds to induce arrhythmias in
the heart, which can lead to “Sudden Cardiac Death”. ThisTertoolen), stefan.braam@
.J. van Meer), robert.passier@
mmery).
r Inc. This is an open access articlerepresents a major toxic hazard for new drugs in pre-clinical
evaluation [1]. In this context, the Food and Drug Administration
recently initiated the “Comprehensive in Vitro Proarrhythmia
Assay” which aims to establish robust methods to assess cardiac
drug safety using hiPSC-CMs. Crucial will be the ability to measure
electrical responses of the cardiomyocytes in an accurate and pre-
dictive yet medium- to high- throughput platform.
Classically, the cardiac action potential (AP) is measured using
patch clamp electrophysiology in current clamp mode. All ionic
currents of which the AP is composed can bemeasured individually
in whole cell voltage clamp and have been studied in detail over
several decades [2e4]. Alterations of one or more of these currents
can lead to serious dysfunction of the heart, such as Torsade de
Pointes (TdP) or prolongation of the “QT interval” on the standard
electrocardiogram. Drug induced changes in the AP can be caused
by modulations in Naþ and Ca2þ inward currents or several of theunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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activated (IKs) currents in human cardiomyocytes (Fig. 1A). Pro-
longation or shortening of repolarization can lead to concomitant
modulation of the QT interval [5e7]. Parameters involved in
determining the magnitude of these AP effects are the AP ampli-
tude (APA; mV), the resting membrane potential (RMP; mV), the
maximal rate of depolarization (Vmax; Vs1) and AP duration at 50%
and 90% of repolarization (APD50, APD90 respectively; ms).
Although these parameters can be accuratelymeasured using patch
clamp electrophysiology, this is labour intensive and requires
highly skilled experienced operators. By contrast, MEAs are much
more user-friendly, are medium- to high- throughput in use but
record the cardiac field potential (FP) instead of the AP. Prolonga-
tion or shortening of FP duration (FPD) are routinely measured on
MEAs and are considered a measure of the APD90 [1], but other
parameters are difficult to extract from FPs although they may
actually contain a high level of information. In practice extraction of
this information is hampered by poor knowledge of the underlying
relationship (transfer function) between the AP and the FP. Herewe
present a robust basis for more informative MEA analysis by
comparing simulated APs with their resulting FPs using an elec-
trical circuit model. We validated our findings by analysis of FPs
recorded on MEAs in hPSC-CMs exposed to drugs with known
effects.2. Material and methods
2.1. Patch clamp electrophysiology
Patch clamp electrophysiology was essentially done as
described previously [8]. Microelectrodes with a resistance be-
tween 2 and 4 MOhm were made from Borosilicate glass (WarnerFig. 1. (A) A ventricular hPSC-CM AP and FP. Composing active currents are schematically de
resistance to the bath; Cam) apical membrane capacitance to the bath; Cjm) cell membrane c
Cbe) electrode capacitance via the bath resistor; Csh) shunt capacitance of the electrode; Rj)
AP (Vm) in the simulation circuit. (C) Measured AP of a spontaneous beating mouse E17.5 c
Chybechev IIR filtering (Fc ¼ 30 Hz) of the AP in panel C. (F) Power spectrum of panel E, pea
Power spectrum of panel G, peak frequency at ~3 Hz.Instruments, GC-150 T) with Flaming/Brown Micropipette Puller
Model 97 (Sutter Instruments, CA). The sampling frequency was
5 kHz. During electrophysiological measurements, cells were kept
in a buffer containing 145 mM NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM
MgCl2, 10 mM D-glucose and 10 mM HEPES, adjusted to pH 7.30
with NaOH. The pipette contained buffer consisting of 145 mM KCl,
5 mM NaCl, 2 mM CaCl2, 4 mM EGTA, 2 mM MgCl2, and 10 mM
HEPES, adjusted to pH 7.30 with KOH.
2.2. Primary cardiomyocytes
Hearts of mouse embryos at embryonic day (E)17.5 were iso-
lated by micro scalpel and washed in low calcium (Ca2þ) medium
for 30 min at room temperature. Tissue fragments were then
incubated in enzyme-containing medium for 25e35 min at 37 C.
Dissociation of the tissue was completed in King's B medium by
gentle shaking at room temperature for 1 h. The isolated cells were
resuspended in Dulbecco's Modified Eagle Medium (DMEM) sup-
plemented with 20% fetal calf serum (FCS) and incubated at 37 C.
MEA chips were plasma cleaned and coated with fibronectin
(40 mg/mL) for 1 h at 37 C. The isolated cardiomyocytes were
allowed to attach to the surface of the MEA for 24 h in DMEM
containing 5% FCS. Mouse experiments were performed conform
EU Directive 2010/63/EU for animal experiments (Leiden University
Medical Center).
2.3. hPSC-CM and differentiation
The human embryonic stem cell (hESC) line HES3 [9] was
routinely cultured on 129SV mouse embryonic fibroblasts (MEFs)
and induced to differentiate to cardiomyocytes as described pre-
viously [8]. Large numbers of contracting areas were obtainedpicted during time. (B) Equivalent circuit of a cell on a MEA. Ram) apical cell membrane
apacitance to junction; Rjm) membrane resistance to the junction; Rb) bath resistance;
junction resistance; Cje) junction capacitance of the electrode; Ip) injection point of the
ardiomyocyte. (D) Power spectrum of panel C, peak frequency at 1 Hz. (E) Result after
k frequency at ~3.5 Hz. (G) Measured FP of a mouse E17.5 cardiomyocyte on a MEA. (H)
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2.4. MEA recordings
MEA chips were plasma-cleaned and coated with fibronectin
(50 mg/mL) for 1 h at 37 C. Clusters of beating hPSC-CMs were
micro-dissected and replated on standard 60 electrode MEAs
(Multi Channel Systems, Reutlingen, Germany). Extracellular
recording was performed using a MEA1060INV MEA amplifier
(Multi Channel Systems). Output signals were digitized at 10 kHz.
Standard measurements were performed in DMEM supplemented
with 5% FCS. During recordings, temperature was kept at 37 C.
Data were recorded using QT-screen (Multi Channel Systems) and
analysed off-line with QT-analyser (Multi Channel Systems) or with
LabVIEW software (see Supplemental Data). The MEAs used had
titanium nitrate electrodes of 30 mm in size and a spacing of
200 mm. TTX was obtained from Alomone Labs (Jerusalem, Israel),
Bay K 8644 from Tocris Bioscience (Bristol, United Kingdom).
2.5. Software and data analysis
Multisim (Multisim 10.1.1 National Instruments, Austin, Texas,
USA) SPICE based software was used for the transformation of APs
to FPs according to the equivalent circuit depicted in Fig. 1B.
3. Results
3.1. Translation from AP to FP
A representative hPSC-CM AP measured by current clamp
electrophysiology and a representative hPSC-CM FP measured by
MEA is depicted in Fig. 1A. The important active currents in the
different phases of the AP and FP are indicated.
The FP of a cell on a MEA electrode can be best understood from
the electronic equivalent circuit (Fig. 1B). The main determinant of
the circuit is the resistor-capacitance combination (Rj-Cje) resem-
bling the junction resistance of the basal cell membrane and the
MEA electrode. From a linear electronic circuit perspective it
functions as a high pass filter. The filter characteristics of a single
MEA electrode is modelled by applying a second order Chybechev
digital infinite impulse response (IIR) filter with a half maximal cut
off frequency (Fc) of 30 Hz on an AP measured on a mouse E17.5
cardiomyocyte (Fig. 1E and C, respectively). Mouse cardiomyocytes
were chosen for comparison of APs and FPs experiments because of
their homogeneity and reproducibility in both electrophysiology
and MEA measurements. Since the filter effect is the most domi-
nant part of the basal cell membrane to electrode transfer function,
we analysed frequency domains of both AP and FP signals by
spectral analysis. Different values for Fc were applied (15e60 Hz) on
the same AP. After the filter step, peak power frequencies were
quantified (Table 1). The 30 Hz filtered example is depicted in
Fig. 1E and F.
Next, the FP of mouse E17.5 cardiomyocytes was recorded with
MEA (Fig. 1G) and spectrally analysed (Fig. 1H). This spectrum wasTable 1
Relationship between filter frequency in the time domain and the peak frequency in
the frequency domain.
Filter frequency (Hz) Peak power frequency of the filtered AP (Hz)
no filter 0.57
15 2.2
30 3.1
45 3.8
60 6.9almost identical to the power spectrum obtained from the filtered
AP (Fig. 1F). Most FPs have a peak power frequency of around
3.5 Hz. This demonstrated that the transfer function of the MEA
electrode can be modelled as a high pass filter with an Fc value
around 30 Hz. The power spectrum of the unfiltered AP is shown in
Fig. 1D.
3.2. Simulations
The underlying electrical transfer function of aMEA seems to act
as a simple second order filter but in reality the final shape of the FP
is dependent on the behaviour of all resistors and capacitors pre-
sent in the circuit. Multisim was used (see Supplemental Data) to
build the equivalent circuit depicted in Fig. 1B connected to a
voltage source in order to inject the AP at node Ip.
Membrane properties of ventricular mouse cardiomyocytes are
well known from patch clamp electrophysiology (typically
Rjm ~ 500MOhm and Cjm ~ 30e70 pF). The contribution of the outer
cell membrane resistance Ram and the capacity Cam on the final
shape of the FP were negligible. Therefore, these components were
not incorporated in our simulation model. Values for Cfb and Csh
were set to 100 pF. Different values for either capacitor did not
affect the final shape of the FP but they could contribute to the
overall noise of the output signal (results not shown). The value for
the resistance of the bath (Rb) was set to 500 Ohm Different sub-
stitutions for these parameters also had negligible effects on the
shape of the resulting FP. Since the analysis of the frequency
domain of MEA FPs revealed a Fc of 30 Hz, the resulting product of
Rj and Cje is ~5 F$Ohm (Eq. (1)).
Fc ¼ 12pRjCje
(1)
An mouse E17.5 cardiomyocyte AP was simulated (Fig. 2A) and
the corresponding FPs were generated using different combina-
tions for Rj and Cje with a product constant of 5 F$Ohm (Fig 2E and
F; Table 2).
3.3. Modulation of the APs and FPs characteristic for hPSC-CMs
3.3.1. Modulation of the inward Naþ current
APs of hPSC-CMs with different upstroke velocities (Naþ cur-
rents) were generated and analysed (Fig. 3A). The upstroke dura-
tion of the AP was varied from 0.25 to 4 ms resulting in Vmax values
of 400 Vs1 to 25 Vs1, respectively. To gain insight into the rela-
tionship between Vmax of the AP versus the slope upstroke (from
initiation to 00 in Fig. 1A) and the slope decay (from 00 to 10 in
Fig. 1A) of the FPs (Fig. 3B) they were plotted against each other and
fitted by linear regression (Fig. 3C and D). Estimation of the slope
upstroke and slope decay of the peak by linear regression was
carried out over the trajectory from 45% to 95% of the peak or 45%e
95% of the minimum amplitude of the FP.
In order to address the robustness of the relationship in practice,
we investigated the effects for different values for Cje and Rj to
model variation in cell attachment. Table 3 shows this behaviour.
For the slope upstroke of the FP, the goodness of fit was relatively
insensitive to different combinations of Cje and Rj. However, the
relationship between Vmax and the slope decay was in general less
linear (Fig. 3D).
To compare the predicted behaviour of our simulations with
actual MEA measurement data, hPSC-CMs were treated with
increasing concentrations of tetrodotoxin (TTX) to block the so-
dium channels selectively. The peaks of the FPs are shown in Fig. 3E.
Both slope upstrokes (Fig. 3F) and slope decays were analysed
(Fig. 3G).
Fig. 2. Simulated AP representative of a mouse E17.5 cardiomyocyte (A) and corresponding SPICE derived FPs with different values for Rj and Cje with a product constant
5000 pF$MOhm (Fc ¼ 30 Hz) (B,C,D and E). Panels (D and E) result into the characteristic FP shape compared to a measured FP of a mouse cardiomyocyte E17.5 (F, repeated from
Fig. 1G).
Table 2
The corresponding FPs are shown in Fig. 2BeE. Combinations with highest junc-
tional resistances (Rj > 50 MOhm) are in good agreement with the measured FPs
from embryonic mouse cardiomyocytes E17.5 on a MEA (Fig. 4F).
Fc (Hz) Rj (MOhm) Cje (pF)
30 5 1000
30 10 500
30 50 100
30 100 50
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3.4.1. APD prolongation, shortening and periodicity
APs were generated where the APD90 of the simulated hPSC-CM
was varied over a range from 180 to 240 ms (Fig. 4A). FPs resulting
from our model are shown in Fig. 4B. The FPDs were defined as the
time between the peak of the upstroke (00 in Fig. 1A) until therepolarization phase (40 in Fig. 1A). The relationship between the
APD and the FPD was assessed by linear regression (Fig. 4G). hPSC-
CMs were then exposed to E-4031 (Fig. 4J) and Bay K 8644 (Fig. 4K)
to shorten and prolong the FPD respectively, andmeasured byMEA.
The dose response curves of the FPD prolongation for the com-
pounds is shown in Fig. 4L and M.
Deviations from regular repetitive contraction, known as
tachyarrhythmias or TdP, are visualized in Poincare diagrams. They
are accurately detected from current clamp recordings (APD and
repetition interval). This method is also applicable to FPs (FPD and
repetition interval) (Supplemental Fig. 2).3.5. Modulation of the potassium currents during repolarization
Differences of APD90-APD70 are used to quantify modulation of
IKr, IKs currents. Triangulation, based on differences in APD90-APD70
(see Supplemental Data), is often used in cardiotoxicity assays [10].
Fig. 3. (A) Simulated APs of hPSC-CMs with different upstroke durations (0.2e4 ms) and (B) the corresponding SPICE derived FPs (Cje ¼ 50 pF; Rj ¼ 100 MOhm). Slope upstroke of
the different APs against the slope upstroke (C) and slope decay (D) of the corresponding SPICE derived FPs. (E) FPs measured from hPSC-CMs, treated with different concentrations
of tetrodotoxine (TTX). Slopes quantified from the upstroke (initiation to 00) (F) and from the decay (00 to 10) (G).
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whether it was possible to derive an indication of triangulation
from FPs by measuring the interval of peak 30 and 40 (FPD4′-FPD3′;
Suppl. Fig. 1). APs and corresponding FPs were generated that
showed a high degree of triangulation (Fig. 4C and D, respectively).
The relationship between the APD90 -APD70 and the FPD4′ -FPD3′
are in reasonably good agreement with a linear relationship
(R2 ¼ 0.9452) (Fig. 4I), while the APD90-APD70 and the FPD4′-FPD3′
of the prolonged APs and FPs without modulation of the potassium
currents during repolarization (Fig. 4E and F, respectively) do not
show triangulation.
To compare the predicted behaviour of our simulations with
actual MEA data, FPs of hPSC-CMs were recorded on MEAs in the
presence of E-4031 (Fig. 4J) and Bay K 8644 (Fig. 4K). E-4031, a class
III antiarrhythmic agent, is well known for decreasing the IKr cur-
rent, while Bay K 8644 induces FDP prolongation by increasing
activation of the L-type Ca2þ channel. Dose response curves for
triangulation (FPD4′-FPD3′) are shown (Fig. 4N and O). As expected,
Bay K 8644 showed FPD prolongation (Fig. 4M) that was not
accompanied by triangulation (Fig. 4O), while E-4031 showed both
FPD prolongation (Fig. 4L) and triangulation (Fig. 4N) which is in
line with our simulations.
4. Discussion
The AP is generated by a fast depolarization of the membrane
potential due to Naþ channel activation. This ensures a strong in-
ward current, activate the L-type Ca2þ channels and induces anincreasing permeability to Kþ as a result of the rapid activation of
transient outward Kþ channels (Ito). In humans, this outward cur-
rent, corresponding to negative change in membrane potential,
allows activation of the rapid delayed rectifier (IKr) and the slow
rectifying (IKs) Kþ channels. Finally it leads to complete repolari-
zation of the cardiomyocyte to its RMP. Commonly, consecutive
changes of these currents can be deduced from changes in shape of
the AP. Here we showed that many of these changes can be derived
from the FP. As a direct result from our simulations, it is possible to
interpret under various conditions which phenomenon underlies
modulation induced by unknown drugs, using our simulation sets
for typecasting. The interpretation and constraints in AP-FP trans-
lation are discussed below for different individual currents.
4.1. Sodium current modulation
Vmax can be derived from both the slope upstroke and slope
decay of the FP which can be obtained by linear regression. It is
important to keep the trajectory over which the regression is
computed well defined. In our study we used levels of 90%e45% of
the peak amplitude. Vmax can be obtainedmore accurately from the
FP when extracted from the slope upstroke compared to the slope
decay since the linearity is higher (respectively R2 ¼ 0.9965 versus
R2 ¼ 0.8725).
4.2. FPD prolongation and shortening
Analysis of the FP duration is one of the most commonly used
Fig. 4. Simulated APs of hPSC-CMs with different durations (180e290 ms) (A) and corresponding SPICE derived FPs (B). The relationship of the APD versus the FPD is shown in panel
G. Simulated APD variation due to Kþ current modulation (C) and corresponding SPICE derived FPs (D). The ADP90-ADP70 values plotted versus the FDP4′-FDP3′ are shown in panel H.
Simulated APD variation without Kþ current modulation (E) and corresponding SPICE derived FPs (F). The ADP90-ADP70 values plotted versus the FDP4′-FDP3′ are shown in panel I.
(J) FPs measured from hPSC-CMs exposed to E-4031. E-4031 evoked changes in Kþ current and FPD prolongation (L) and modulation of the FDP4′-FDP3′ (N). Bay K 8644 (K) induced
prolongation (M) without modulation of the FDP4′-FDP3′ (O).
Table 3
Linearity between Vmax and slope upstroke and slope decay of the
FP for different combinations of Cje and Rj .
Cje ¼ 50 pF Rj ¼ 100 MOhm R2
slope upstroke versus Vmax 0.9965
slope decay versus Vmax 0.8725
Cje ¼ 100 pF Rj ¼ 50 MOhm R2
slope upstroke versus Vmax 0.9946
slope decay versus Vmax 0.7031
Cje ¼ 500 pF Rj ¼ 10 MOhm R2
slope upstroke versus Vmax 0.9980
slope decay versus Vmax 0.8116
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linear relationship (R2 ¼ 0.999) between the AP duration and the
duration of the resulting FP. We did not observe any deviation from
linearity under varying conditions using different values of Cje and
Rj with a constant product (Fc ¼ 30 Hz, data not shown) modelling
differences in cell attachment.
4.3. Modulation of the potassium currents during repolarization
In humans, drug-induced block of the rapid component of the
Kþ channels (IKr or IKs) can induce ventricular tachyarrhythmias inthe heart known as TdP. As a result, assays that measure IKr block
have become standard tools for assessing cardiac hazard [11]. Here
we show with simulations and known drugs that the presence of
changes in APD90-APD70 measured from APs can be equally well
detected and predicted by analysis of corresponding points from
FPs (FPD4′-FPD3′).
In conclusion, to our knowledge we presented here the first
comprehensive description of the cardiac FP in relation to cardiac
toxicity screening and modulation of the underlying currents. We
propose that it will improve the analysis of cardiac toxicity
screening of cardiomyocytes using MEAs in general, but in partic-
ular of human in vitromodels based on hPSC-CMs (hiPSC- or hESC-
CMs). The approach we describe could serve as a framework for
future medium- and high-throughput screening of new drugs and
compounds for their potential harmful effects on the human heart.
Funding
Work in the Mummery lab is supported by the European
Research Council [grant number ERCAdG 323182
STEMCARDIOVASC].
Acknowledgements
We thank D. Ward-van Oostwaard and J. Monshouwer-Kloots
for expert technical assistance with the cultures and isolations of
L.G.J. Tertoolen et al. / Biochemical and Biophysical Research Communications 497 (2018) 1135e1141 1141mouse cardiomyocytes.
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.bbrc.2017.01.151.
Transparency document
Transparency document related to this article can be found
online at http://dx.doi.org/10.1016/j.bbrc.2017.01.151.
References
[1] S.R. Braam, L. Tertoolen, A. van de Stolpe, T. Meyer, R. Passier, C.L. Mummery,
Prediction of drug-induced cardiotoxicity using human embryonic stem cell-
derived cardiomyocytes, Stem Cell Res. 4 (2010) 107e116.
[2] K.R. Boheler, J. Czyz, D. Tweedie, H.T. Yang, S.V. Anisimov, A.M. Wobus, Dif-
ferentiation of pluripotent embryonic stem cells into cardiomyocytes, Circ.
Res. 91 (2002) 189e201.
[3] G.-R. Li, C.-P. Lau, T.-K. Leung, S. Nattel, Ionic current abnormalities associated
with prolonged action potentials in cardiomyocytes from diseased human
right ventricles, Heart Rhythm 1 (2004) 460e468.
[4] J. Ma, L. Guo, S.J. Fiene, B.D. Anson, J.a Thomson, T.J. Kamp, K.L. Kolaja,B.J. Swanson, C.T. January, High purity human-induced pluripotent stem cell-
derived cardiomyocytes: electrophysiological properties of action potentials
and ionic currents, AJP Hear. Circ. Physiol. 301 (2011) H2006eH2017.
[5] Y. Tsuji, T. Opthof, K. Yasui, Y. Inden, H. Takemura, N. Niwa, Z. Lu, J.-K. Lee,
H. Honjo, K. Kamiya, I. Kodama, Ionic mechanisms of acquired QT prolonga-
tion and torsades de pointes in rabbits with chronic complete atrioventricular
block, Circulation 106 (2002) 2012e2018.
[6] Y. Tsuji, S. Zicha, X.Y. Qi, I. Kodama, S. Nattel, Potassium channel subunit
remodeling in rabbits exposed to long-term bradycardia or tachycardia:
discrete arrhythmogenic consequences related to differential delayed-rectifier
changes, Circulation 113 (2006) 345e355.
[7] P.G.A. Volders, K.R. Sipido, M.A. Vos, R.L.H.M.G. Sp€atjens, J.D.M. Leunissen,
E. Carmeliet, H.J.J. Wellens, Downregulation of Delayed Rectifier Kþ Currents
in Dogs With Chronic Complete Atrioventricular Block and Acquired Torsades
de Pointes, Circulation 100 (1999) 2455e2461.
[8] C. Mummery, D. Ward-van Oostwaard, P. Doevendans, R. Spijker, S. van den
Brink, R. Hassink, M. van der Heyden, T. Opthof, M. Pera, A.B. de la Riviere,
R. Passier, L. Tertoolen, Differentiation of human embryonic stem cells to
cardiomyocytes: role of coculture with visceral endoderm-like cells, Circula-
tion 107 (2003) 2733e2740.
[9] M. Costa, M. Dottori, E. Ng, S.M. Hawes, K. Sourris, P. Jamshidi, M.F. Pera,
A.G. Elefanty, E.G. Stanley, The hESC line Envy expresses high levels of GFP in
all differentiated progeny, Nat. Methods 2 (2005) 259e260.
[10] P. Champeroux, E. Martel, C. Vannier, V. Blanc, J.Y. Leguennec, J. Fowler,
S. Richard, The preclinical assessment of the risk for QT interval prolongation,
Therapie 55 (2000) 101e109.
[11] B. Fermini, A.A. Fossa, The impact of drug-induced QT interval prolongation on
drug discovery and development, Nat. Rev. Drug Discov. 2 (2003) 439e447.
